158 related articles for article (PubMed ID: 21849853)
1. Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients.
Takahashi Y; Ishii G; Taira T; Fujii S; Yanagi S; Hishida T; Yoshida J; Nishimura M; Nomori H; Nagai K; Ochiai A
J Thorac Oncol; 2011 Sep; 6(9):1460-7. PubMed ID: 21849853
[TBL] [Abstract][Full Text] [Related]
2. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung.
Taira T; Ishii G; Nagai K; Yoh K; Takahashi Y; Matsumura Y; Kojima M; Ohmatsu H; Goto K; Niho S; Takashima H; Inoue H; Ohe Y; Ochiai A
Lung Cancer; 2012 Jun; 76(3):423-30. PubMed ID: 22153829
[TBL] [Abstract][Full Text] [Related]
4. Laminin-5γ2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinoma.
Masuda R; Kijima H; Imamura N; Aruga N; Nakazato K; Oiwa K; Nakano T; Watanabe H; Ikoma Y; Tanaka M; Inokuchi S; Iwazaki M
Biomed Res; 2012; 33(5):309-17. PubMed ID: 23124251
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
Kim MY; Koh J; Kim S; Go H; Jeon YK; Chung DH
Lung Cancer; 2015 Apr; 88(1):24-33. PubMed ID: 25662388
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma.
Li J; Chen H; Li X; Wang L; Gao A; Zhang P; Lin W; Gao W; Yang D; Guo X; Liu J; Dang Q; Sun Y
Mol Med Rep; 2017 Aug; 16(2):1643-1652. PubMed ID: 28656229
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer.
Li J; Wei Z; Li H; Dang Q; Zhang Z; Wang L; Gao W; Zhang P; Yang D; Liu J; Sun Y; Gao W
Hum Pathol; 2015 Dec; 46(12):1821-8. PubMed ID: 26391572
[TBL] [Abstract][Full Text] [Related]
8. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung.
Ueda T; Aokage K; Nishikawa H; Neri S; Nakamura H; Sugano M; Tane K; Miyoshi T; Kojima M; Fujii S; Kuwata T; Ochiai A; Kusumoto M; Suzuki K; Tsuboi M; Ishii G
J Cancer Res Clin Oncol; 2018 May; 144(5):835-844. PubMed ID: 29435735
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.
Matsuwaki R; Ishii G; Zenke Y; Neri S; Aokage K; Hishida T; Yoshida J; Fujii S; Kondo H; Goya T; Nagai K; Ochiai A
Cancer Sci; 2014 Jul; 105(7):905-11. PubMed ID: 24814677
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
14. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin expression is correlated with the prognosis of lung squamous cell carcinoma.
Ikoma Y; Kijima H; Masuda R; Tanaka M; Inokuchi S; Iwazaki M
Biomed Res; 2015; 36(6):393-402. PubMed ID: 26700593
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
[TBL] [Abstract][Full Text] [Related]
18. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
19. Role of the extracellular matrix in variations of invasive pathways in lung cancers.
de Sá VK; Carvalho L; Gomes A; Alarcão A; Silva MR; Couceiro P; Sousa V; Soares FA; Capelozzi VL
Braz J Med Biol Res; 2013 Jan; 46(1):21-31. PubMed ID: 23314337
[TBL] [Abstract][Full Text] [Related]
20. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.
Tsuta K; Kozu Y; Mimae T; Yoshida A; Kohno T; Sekine I; Tamura T; Asamura H; Furuta K; Tsuda H
J Thorac Oncol; 2012 Feb; 7(2):331-9. PubMed ID: 22198430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
